Many biotech, pharma, and medical device companies based outside the United States need people in the US before they have a US company. The first hire might be a regulatory lead, a clinical operations specialist, or a business development director.
That raises a practical question. Is an Employer of Record (EoR) enough, or does the company need its own US entity? This article covers what an EoR handles, the signs you have outgrown it, what FDA actually requires of foreign sponsors, and how to move between the two cleanly.
Who this guide is for
This guide is for leaders at life sciences companies headquartered outside the US who are making their first US hires. Typical early roles include regulatory affairs, clinical development and operations, medical affairs, alliance management, and a US country or site lead. If you already have a US subsidiary, see How to Blend Contract, FSP, and Permanent Teams in Life Sciences.
What an Employer of Record covers
An EoR is the legal US employer for the people you designate. It runs payroll, withholds and pays employment taxes, provides benefits and insurance, and handles employment compliance. Your company directs the day to day work, assignments, and priorities. With no company to form first, it is usually the fastest route for a first wave of hires.
An EoR has limits. It does not sign your contracts with US clinical sites, vendors, or customers. It does not give you a US bank account or legal counterparty, and it is not your FDA sponsor. Your management decisions remain your responsibility. Ownership of work product and inventions is set in the client agreement, which our Employer of Record services page explains. For the broader administrative and compliance benefits, see Benefits of Using an Employer of Record (EoR) or Professional Employment Organization (PEO).
Signs you need your own US entity
No single headcount number decides this. The better question is what your US team does and whether it is becoming permanent.
Your US team is becoming permanent
A few hires for a defined program fit an EoR well. A US function that will exist for years, with its own leadership, usually belongs in your own company. As the team grows, note that the IRS employer shared responsibility provisions apply to employers with 50 or more full time employees, including full time equivalents.
You need to sign US contracts or leases in your own name
Lab and office leases, US clinical site and vendor agreements, distribution partners, and customers who want a US counterparty all push toward a US entity.
You will book US revenue
Invoicing US customers, holding a US bank account, and filing US tax returns are easier through a US company. US activity can also create tax questions for the parent even when people are employed through an EoR, so involve tax advisers early. The IRS keeps a list of US income tax treaties that may apply to your home country.
Investors, partners, or employees expect a US company
US investors may prefer a US corporation. Offering equity to US staff is usually simpler through a US entity. If you plan to move a manager to the US on an L-1 visa, USCIS requires a qualifying relationship between the foreign company and a US parent, branch, subsidiary, or affiliate.
Your regulatory program is scaling up
This is where many teams assume they must form a company. FDA does not require a US entity to sponsor an IND. Under 21 CFR 312.23(a)(1)(ix), if the person signing the application does not reside or have a place of business in the United States, the IND must be countersigned by an attorney, agent, or other authorized official who does. FDA’s definition of a sponsor does not require US incorporation, and a sponsor may transfer obligations to a contract research organization in writing.
Even so, many foreign sponsors form a US entity as their clinical programs grow. The entity can hold site and vendor contracts and employ the US clinical, regulatory, and quality and regulatory team. That is a business decision, not an FDA rule. This is general information, not legal or regulatory advice. Confirm your structure with regulatory and corporate counsel.
A common path: start with an EoR, then move to your entity
Many companies hire their first US people through an EoR, start forming the entity when the signs above appear, and run both structures in parallel until the entity is ready.
Timing
Plan backward from the date people will move, and set that date only after the entity can actually run payroll. That means an Employer Identification Number, a US bank account, payroll withholding and unemployment registrations in each state where people work, workers’ compensation coverage, a payroll provider, and benefit plans with confirmed start dates. Moving on the first day of a month or pay period keeps things simple.
A clean transfer
In the US, employees usually leave the EoR and are hired by the new entity on an agreed date. There is no automatic transfer of employment like those found in some European systems. Give the EoR notice under your agreement. Issue new offer letters and employment agreements. Have employees complete a new Form W-4 and Form I-9. Line up benefits so coverage has no gap, and decide how you will treat service dates and accrued paid time off. Tell employees early, since a change of employer matters even when the job stays the same.
EoR vs US entity at a glance
| Employer of Record | Your own US entity | |
|---|---|---|
| Speed to first hire | Fastest, with no company to form first | Slower, since the entity, EIN, bank account, and state registrations come first |
| Cost structure | A per person service fee on top of pay and benefits | Setup costs plus fixed ongoing legal, accounting, filing, payroll, and benefits costs |
| Control | You direct the work, and the EoR’s policies and benefit plans apply | Full control of policies, benefits, equity, and organization design |
| Liability and compliance | The EoR handles employment administration, and you still own management decisions and any tax exposure from US activity | The entity carries employer obligations directly and separates US obligations from the parent company |
| Contracts and FDA | The foreign parent signs contracts and can sponsor an IND with a US countersignatory | The entity can sign US contracts and can hold the IND if you choose |
| Best fit | First hires such as a regulatory lead, clinical operations, medical affairs, or business development | A growing permanent team across clinical, regulatory, quality, commercial, and leadership |
How GForce helps at each stage
Before you have a US company, our Employer of Record services employ your first US professionals, including people you have already identified. As your work grows, we provide contract consulting and staffing for defined projects, Functional Service Provider teams for steady clinical or data work, and direct hire and executive search for permanent US leadership. When your entity is ready, employees can move from GForce to your company under the terms of the agreement and applicable employment rules.
We support life sciences clients based in Asia, Oceania, Europe, and the United States.
Frequently Asked Questions
Can a foreign biotech hire US employees without a US entity?
Yes. An Employer of Record can serve as the legal US employer. The EoR runs payroll, tax withholding, benefits, and employment compliance, while your company directs the day to day work. This lets you hire your first US people before forming a subsidiary.
Does a foreign company need a US entity to sponsor an IND?
No. Under 21 CFR 312.23(a)(1)(ix), if the person signing the IND does not reside or have a place of business in the United States, the application must be countersigned by a US based attorney, agent, or other authorized official. Many sponsors still form a US entity later for business reasons. Confirm your approach with regulatory counsel.
Is an FDA US agent the same as an IND countersignatory?
Not necessarily. Foreign drug and device establishments name a US agent for facility registration under 21 CFR 207.69 and 21 CFR 807.40. The IND countersignature is a separate requirement under 21 CFR 312.23(a)(1)(ix), so check which role you need before you appoint someone.
When should we move from an EoR to our own US entity?
Consider an entity when your US team is becoming permanent, when you need to sign US contracts or leases, book US revenue, offer a US equity plan, or use intracompany transfer visas, or when investors and partners expect a US company. No single headcount number decides it.
How do employees move from an EoR to a new US entity?
Employees usually leave the EoR and are hired by the new entity on an agreed date, once the entity can run payroll in each state where they work. Plan new employment agreements, Forms W-4 and I-9, benefits without a coverage gap, and how service dates and paid time off carry over.
Can GForce support us before and after we form a US entity?
Yes. GForce can serve as your Employer of Record for your first US hires, then provide contract, FSP, and direct hire support as your US team grows. When your entity is ready, employees can move from GForce to your company under the terms of the agreement.
GForce Life Sciences is a leading talent partner delivering precise recruiting and workforce solutions to biotech, pharma, and medical device organizations. If you are planning your first US hires or your move to a US entity, contact us today.